Skip to main content
Premium Trial:

Request an Annual Quote

NCI, NHGRI Pledge $50M Each for Pilot Cancer Genome Project

NEW YORK, Aug. 1 (GenomeWeb News) - The National Cancer Institute and National Human Genome Research Institute have committed to contribute $50 million each to kick off an effort to collect and analyze all the genetic mutations found in human cancers.

 

The commitment, which still requires approval from the institutes' scientific advisory boards and councils, comes after an NCI and NHGRI-sponsored workshop held last month to get input from members of the scientific community on how best to achieve the project's goal.

 

The pilot phase of the effort will "focus on addressing the wide range of challenges in cancer biology and technology that must be met in order to implement a successful large-scale human cancer genome project," according to the National Institutes of Health. "The initial phases also will analyze whether the comprehensive cataloguing of the sequence changes in cancer will prove useful in understanding cancer and lead to new methods of diagnosis and treatment."

 

Initial work on the pilot project, which is anticipated to take three years, is set to begin in 2006.

 

Additional information on the cancer genome effort is expected to be available in a forthcoming report from the July workshop, NIH said.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.